Clinical Trials on Microvascular Disease in New Zealand
Total 43893 results
-
PfizerArena is a wholly owned subsidiary of PfizerTerminatedMicrovascular ObstructionUnited States, Australia, Netherlands, Sweden, United Kingdom
-
NYU Langone HealthRecruitingMyocardial Ischemia | Ischemic Heart Disease | Coronary Microvascular DiseaseUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Yale UniversityAbbottRecruitingEndothelial Dysfunction | Coronary Vasospasm | Microvascular Angina | Coronary Microvascular Dysfunction | Ischemia and No Obstructive Coronary Artery Disease | Chest Pain With Normal Coronary AngiographyUnited States
-
Vitreous -Retina- Macula Consultants of New YorkRegeneron PharmaceuticalsWithdrawnFibrovascular Pigment Epithelial DetachmentUnited States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Zealand University HospitalUniversity of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...CompletedDepression | Acute Coronary SyndromeDenmark
-
Mylan Inc.Theravance BiopharmaCompleted
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
W.L.Gore & AssociatesCompletedPeripheral Arterial Disease | Common Iliac Artery Occlusive Disease | External Iliac Artery Occlusive DiseaseNew Zealand
-
Medtronic VascularCompletedMyocardial Ischemia | Coronary Artery DiseaseNew Zealand
-
Living Cell TechnologiesCompletedParkinson's DiseaseNew Zealand
-
Living Cell TechnologiesStatistecol Consultants LimitedCompleted
-
Shockwave Medical, Inc.Completed
-
Liggins InstituteRecruiting
-
Hoffmann-La RocheCompletedEnd Stage Renal DiseaseNew Zealand
-
EndologixCompletedPeripheral Arterial DiseaseNew Zealand
-
Avinger, Inc.WithdrawnPeripheral Arterial DiseaseNew Zealand
-
NeuroActiva, Inc.CompletedNeurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive DisorderNew Zealand
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
GlaxoSmithKlineCompletedKidney DiseaseNew Zealand
-
Academy of Nutrition and DieteticsCompletedEnd Stage Renal Disease Requiring HemodialysisNew Zealand
-
Gilead SciencesCompleted
-
Arrowhead PharmaceuticalsRecruitingIgA NephropathyNew Zealand
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
University of Auckland, New ZealandAuckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...CompletedPolycystic Ovary SyndromeNew Zealand
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Capital and Coast District Health boardWellington Southern Community Laboratories; Institute of Environmental Science...RecruitingBacterial InfectionsNew Zealand
-
Bardy Diagnostics, Inc.UnknownAtrial Fibrillation | Syncope | Supraventricular Tachycardia | Presyncope | PalpitationsNew Zealand
-
Fisher and Paykel HealthcareTerminatedObesity Hypoventilation SyndromeNew Zealand
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
University of Auckland, New ZealandCompleted
-
University of Auckland, New ZealandCompletedPostoperative Pain | HemorrhoidsNew Zealand
-
Intervene, Inc.Terminated
-
Zimmer BiometCompleted
-
Tavotek BiotherapeuticsRecruiting
-
Gilead SciencesCompletedUlcerative ColitisNew Zealand
-
Arthrosi TherapeuticsCompletedGout PatientsNew Zealand
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Arcturus Therapeutics, Inc.Novotech CRORecruiting
-
Arrowhead PharmaceuticalsRecruitingFacio-Scapulo-Humeral DystrophyNew Zealand
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
University of Auckland, New ZealandCompleted